Prygiel M, Mosiej E, Wdowiak K, Zasada A
Biomedicines. 2025; 12(12.
PMID: 39767826
PMC: 11673946.
DOI: 10.3390/biomedicines12122920.
Woodland B, Coorssen J, Padula M
Front Cell Dev Biol. 2024; 12:1504098.
PMID: 39720005
PMC: 11666697.
DOI: 10.3389/fcell.2024.1504098.
Sheehan K, Jeon H, Corr S, Hayes J, Mok K
Protein J. 2024; 44(1):1-20.
PMID: 39527351
DOI: 10.1007/s10930-024-10237-6.
Apiwat C, Houghton J, Ren R, Tate E, Edel J, Chanlek N
ACS Omega. 2024; 9(39):40592-40607.
PMID: 39371982
PMC: 11447712.
DOI: 10.1021/acsomega.4c04276.
Bourel L, Bray F, Vivier S, Flament S, Guilbert L, Chepy A
J Proteome Res. 2024; 23(9):3933-3943.
PMID: 39140748
PMC: 11468067.
DOI: 10.1021/acs.jproteome.4c00268.
Thrombin: An Approach to Developing a Higher-Order Reference Material and Reference Measurement Procedure for Substance Identity, Amount, and Biological Activities.
Jackson C, Esnouf P, Duewer D
J Res Natl Inst Stand Technol. 2024; 125:125021.
PMID: 39035347
PMC: 10871826.
DOI: 10.6028/jres.125.021.
Protecting children and adults with primary antibody deficiencies against common and emergent pathogens and non-infectious complications.
Neth O, Mahlaoui N, Cunningham-Rundles C
Clin Exp Immunol. 2024; 218(2):136-150.
PMID: 39011978
PMC: 11482499.
DOI: 10.1093/cei/uxae059.
Prognostic significance of alpha-2-macrglobulin and low-density lipoprotein receptor-related protein-1 in various cancers.
Olbromski M, Mrozowska M, Piotrowska A, Kmiecik A, Smolarz B, Romanowicz H
Am J Cancer Res. 2024; 14(6):3036-3058.
PMID: 39005669
PMC: 11236788.
DOI: 10.62347/VUJV9180.
Proof of concept of a new plasma complement Factor H from waste plasma fraction.
Mori F, Pascali G, Berra S, Lazzarotti A, Panetta D, Rocchiccioli S
Front Immunol. 2024; 15:1334151.
PMID: 38919628
PMC: 11197005.
DOI: 10.3389/fimmu.2024.1334151.
Addition of sodium malonate alters the morphology and increases the critical flux during tangential flow filtration of precipitated immunoglobulins.
Behboudi A, Minervini M, Badinger Z, Haddad W, Zydney A
Protein Sci. 2024; 33(6):e5010.
PMID: 38723172
PMC: 11081521.
DOI: 10.1002/pro.5010.
New orphan disease therapies from the proteome of industrial plasma processing waste- a treatment for aceruloplasminemia.
Zanardi A, Nardini I, Raia S, Conti A, Ferrini B, DAdamo P
Commun Biol. 2024; 7(1):140.
PMID: 38291108
PMC: 10828504.
DOI: 10.1038/s42003-024-05820-7.
Non-viral and viral delivery systems for hemophilia A therapy: recent development and prospects.
Zangi A, Amiri A, Pazooki P, Soltanmohammadi F, Hamishehkar H, Javadzadeh Y
Ann Hematol. 2023; 103(5):1493-1511.
PMID: 37951852
DOI: 10.1007/s00277-023-05459-0.
A Synopsis of Proteins and Their Purification.
Walls D, Cooney G, Loughran S
Methods Mol Biol. 2023; 2699:1-14.
PMID: 37646990
DOI: 10.1007/978-1-0716-3362-5_1.
Polyoxazoline-conjugated porcine serum albumin as an artificial plasma expander for dogs.
Okamoto W, Usui T, Hasegawa M, Kobayashi T, Fujisawa J, Taguchi K
Sci Rep. 2023; 13(1):9512.
PMID: 37316550
PMC: 10267181.
DOI: 10.1038/s41598-023-35999-4.
Uses and Challenges of Antiviral Polyclonal and Monoclonal Antibody Therapies.
Struble E, Rawson J, Stantchev T, Scott D, Shapiro M
Pharmaceutics. 2023; 15(5).
PMID: 37242780
PMC: 10224075.
DOI: 10.3390/pharmaceutics15051538.
Frozen fresh blood plasma preserves the functionality of native human α-macroglobulin.
Mendes S, Gomis-Ruth F, Goulas T
Sci Rep. 2023; 13(1):4579.
PMID: 36941303
PMC: 10027685.
DOI: 10.1038/s41598-023-31800-8.
The Evolution of the Safety of Plasma Products from Pathogen Transmission-A Continuing Narrative.
Farrugia A
Pathogens. 2023; 12(2).
PMID: 36839590
PMC: 9967166.
DOI: 10.3390/pathogens12020318.
Phthalates in Albumin from Human Serum: Implications for Assisted Reproductive Technology.
Hughes J, Soto-Heras S, Muller C, Miller D
F S Rev. 2022; 2(2):160-168.
PMID: 36268475
PMC: 9580017.
DOI: 10.1016/j.xfnr.2020.12.002.
Incidence and risk factors for intravenous immunoglobulin-related hemolysis: A systematic review of clinical trial and real-world populations.
Cuesta H, El Menyawi I, Hubsch A, Hoefferer L, Mielke O, Gabriel S
Transfusion. 2022; 62(9):1894-1907.
PMID: 35916266
PMC: 9545798.
DOI: 10.1111/trf.17028.
Human Intramuscular Hyperimmune Gamma Globulin (hIHGG) Anti-SARS-CoV-2-Characteristics of Intermediates and Final Product.
Lachert E, Lasocka J, Bielawski A, Sulkowska E, Guz K, Pyrc K
Viruses. 2022; 14(6).
PMID: 35746798
PMC: 9227433.
DOI: 10.3390/v14061328.
